Alterations in expression of retinoid receptor beta and p53 in oral submucous fibrosis.

OBJECTIVE Knowledge of the molecular pathogenesis of oral submucous fibrosis (OSF), a potentially malignant condition with high risk of transition to oral cancer, is meagre. Alterations in the expression of retinoic acid receptor beta (RARbeta) and tumor suppressor gene, p53 are early events in oral tumorigenesis. The aim of this study was to investigate the alterations in the expression of RARbeta and p53 in OSF lesions and determine their association with disease pathogenesis. METHODS The expression of RARbeta and p53 proteins was analyzed by immunohistochemistry in 50 cases of OSF and 30 histologically normal oral tissues. RESULTS No detectable RARbeta expression was observed in 35 of 50 (70%) OSF cases. p53 protein accumulation was observed in 24 of 50 (48%) OSF cases analyzed. Thirty-six percent OSF lesions showed loss of RARbeta and p53 overexpression. Interestingly, 41 of 50 (82%) of OSF lesions showed altered expression of at least one of these two proteins. CONCLUSION Altered expression of either RARbeta or p53 in majority of OSF lesions suggests their association with disease pathogenesis and warrants follow-up to determine whether OSF lesions harboring concomitant alterations in RARbeta and p53 are at a high risk of transition to malignancy.

[1]  Y. Ko,et al.  The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan , 2003, British Journal of Cancer.

[2]  R. Ralhan,et al.  Expression of RARα and RARβ in human oral potentially malignant and neoplastic lesions , 2001 .

[3]  R. Lotan,et al.  Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines. , 2000, Cancer letters.

[4]  E. Mezey,et al.  Effect of retinoic acid on the enhancing effect of acetaldehyde on mouse type I collagen expression. , 2000, Archives of biochemistry and biophysics.

[5]  R. Lotan,et al.  Differential expression of nuclear retinoid receptors in normal and malignant prostates. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  B. Zemel,et al.  Longitudinal analysis shows serum carotenoid concentrations are low in children with cystic fibrosis. , 1999, Journal of the American Dietetic Association.

[7]  R. DiPaola,et al.  Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  P. Viens,et al.  Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma. , 1999, Anti-cancer drugs.

[9]  N. Johnson,et al.  p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[10]  N. Johnson,et al.  p53 expression in oral precancer as a marker for malignant potential. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[11]  R. Ralhan,et al.  Prognostic significance of p53 protein overexpression in betel‐ and tobacco‐related oral oncogenesis , 1998, International journal of cancer.

[12]  Y. Uchida,et al.  Effect of tazarotene, an acetylenic retinoid, on human dermal fibroblast. , 1998, Japanese journal of pharmacology.

[13]  G. Hortobagyi,et al.  Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. , 1997, Cancer research.

[14]  H. Herbst,et al.  Retinoic acid receptor beta regulates growth and differentiation in human pancreatic carcinoma cells. , 1997, Gastroenterology.

[15]  R. Lotan,et al.  Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. , 1997, Journal of the National Cancer Institute.

[16]  D. M. Walker,et al.  Oral submucous fibrosis. A review. , 1996, Australian dental journal.

[17]  P. Chambon.  A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  S. Minucci,et al.  RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  D. M. Walker,et al.  Epithelial growth fraction and expression of p53 tumour suppressor gene in oral submucous fibrosis. , 1996, Australian dental journal.

[20]  S. Li,et al.  Modulation of limb bud chondrogenesis by retinoic acid and retinoic acid receptors. , 1995, The International journal of developmental biology.

[21]  T. Shigematsu,et al.  Modulation of collagen synthesis and cell proliferation by retinoids in human skin fibroblasts. , 1995, Journal of dermatological science.

[22]  M. Krupsky,et al.  Retinoic acid-induced inhibition of type I collagen gene expression by human lung fibroblasts. , 1994, Biochimica et biophysica acta.

[23]  R. Ralhan,et al.  Overexpression of p53 protein in betel‐ and tobacco‐related human oral dysplasia and squamous‐cell carcinoma in India , 1994, International journal of cancer.

[24]  C. V. van Wyk,et al.  Observations on the effect of areca nut extracts on oral fibroblast proliferation. , 1994, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[25]  S. Guichard,et al.  Response of four human ovarian carcinoma cell lines to ALL‐TRANS retinoic acid: Relationship with induction of differentiation and retinoic acid receptor expression , 1994, International journal of cancer.

[26]  P Chambon,et al.  Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Chambon,et al.  Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. , 1992, Molecular endocrinology.

[28]  P. Chambon,et al.  Multiplicity generates diversity in the retinoic acid signalling pathways. , 1992, Trends in biochemical sciences.

[29]  D. Sugarbaker,et al.  High frequency of retinoic acid receptor beta abnormalities in human lung cancer. , 1991, Oncogene.

[30]  T. Hirano,et al.  Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. , 1991, Journal of immunology.

[31]  Christine Chomienne,et al.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.

[32]  H. Stunnenberg,et al.  Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene , 1990, Nature.

[33]  W. Harvey,et al.  Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. , 1986, Archives of oral biology.

[34]  P. Gupta,et al.  Malignant transformation rate in oral submucous fibrosis over a 17-year period. , 1985, Community dentistry and oral epidemiology.

[35]  P. Gupta,et al.  Incidence and early forms of oral submucous fibrosis. , 1980, Oral surgery, oral medicine, and oral pathology.